IMCD NV Quote - IMCD

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

140.15

Bid

137.65

Ask

141.80

Volume

92,211

138.20 Day's Range 140.40

126.65 52 Week Range 169.05

Market Cap

7.987B

Previous Close

137.35

Open

138.20

Last Trade

140.15

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

88,547

Shares Outstanding

56,988,000

Dividend Yield

PE Ratio

27.33

Earnings Per Share (EPS)

5.13

Revenue

4.47B

Net Profit

292.27M

Sector

Chemicals & Chem Preps, Nec

Industry

Chemicals & Chem Preps, Nec

Website

www.imcdgroup.com

Headquarters

Rotterdam, South Holland, Nld

Founded

IMCD NV is listed in the Chemicals & Chem Preps sector of the Euronext with ticker IMCD. The last closing price for IMCD NV was 137.35 €. Over the last year, IMCD NV shares have traded in a share price range of 126.65 € to 169.05 €.

IMCD NV currently has 56,988,000 shares outstanding. The market capitalization of IMCD NV is 7.83 € billion. IMCD NV has a price to earnings ratio (PE ratio) of 27.33.

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares

IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART...

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY

IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE...

IMCD reports EBITA of EUR 403 million in the first nine months of 2024

IMCD reports EBITA of EUR 403 million in the first nine months of 2024 Rotterdam, The Netherlands (8 November 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and...

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America

IMCD acquires Blumos Group to accelerate its growth in the life science markets in Latin America ROTTERDAM, The Netherlands (17 October 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading...

IMCD successfully issues a EUR 500 million rated bond

IMCD successfully issues a EUR 500 million rated bond ROTTERDAM, The Netherlands (29 August 2024, 17:45 hrs CEST) – IMCD N.V. (“IMCD”) a leading distributor of speciality chemicals and food...

IMCD reports EBITA of EUR 270 million in the first half of 2024

IMCD reports EBITA of EUR 270 million in the first half of 2024 Rotterdam, The Netherlands (2 August 2024) - IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner, and formulator...

IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica

IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of...

Shareholders IMCD N.V. adopt all resolutions at AGM

Shareholders IMCD N.V. adopt all resolutions at AGM ROTTERDAM, The Netherlands (14 May 2024, 17:00 hrs CEST) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner...

IMCD reports EBITA of EUR 127 million in the first three months of 2024

IMCD reports EBITA of EUR 127 million in the first three months of 2024 Rotterdam, The Netherlands (26 April 2024) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner...

IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma

IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. (“IMCD” or “Company”), a leading distributor of...